Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11464807 Genetically engineered hematopoietic stem cells and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Date Filed

April 5, 2021

0

Date of Patent

October 11, 2022

0

Patent Application Number

17222765

0

Patent Citations

US Patent 10548922 Methods and compositions for gene editing in hematopoietic stem cells

0

US Patent 10660919 Compositions and methods for inhibition of lineage specific antigens

0

US Patent 10668103 Compositions and methods for inhibition of lineage specific antigens

US Patent 10786535 Compositions and methods for inhibition of lineage specific antigens

US Patent 10925902 Genetically engineered hematopoietic stem cells and uses thereof

US Patent 10912799 Compositions and methods for inhibition of lineage specific antigens

0

US Patent 11033619 Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form

0

US Patent 10137155 Compositions and methods for inhibition of lineage specific antigens

0

US Patent 10201606 Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases

0

Patent Citations Received

US Patent 11975029 Compositions and methods for inhibition of lineage specific proteins

0

US Patent 11903973 Genetically engineered hematopoietic stem cells and uses thereof

0

Patent Inventor Names

Aleksandar Filip Radovic-Moreno

0

Joseph Bolen

0

John Lydeard

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

0

Patent Primary Examiner

Karen Cochrane Carlson

0

CPC Code

0

0

0

G01N 2333/70596

0

0

Find more entities like US Patent 11464807 Genetically engineered hematopoietic stem cells and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool